无症状COVID-19病例的胸部CT表现:系统评价与Meta分析
该系统评价与Meta分析检索PubMed和EMBASE至2020年5月1日,纳入7项研究共231例无症状COVID-19病例,汇总估计胸部CT阳性率为63%(95%CI 44-78%),磨玻璃影(GGO)单独出现率为71%(95%CI 50-86%)。在155例随访病例中,90例保持无症状,65例出现症状;保持无症状者CT阳性率为62%(95%CI 38-81%),出现症状者为90%(95%CI 49-99%)。
要点
- 无症状COVID-19病例胸部CT阳性率汇总为63%(95%CI 44-78%),不可因无症状而排除。
- CT表现以GGO最常见,单独GGO汇总率为71%(95%CI 50-86%)。
- 初诊无症状且CT阳性者后续出现症状的汇总率为26%(95%CI 14-43%)。
关键影像表现/征象
- 胸部CT阳性表现总体汇总率为63%(95%CI 44-78%)。
- 单独GGO的汇总率为71%(95%CI 50-86%)。
- 231例中22例有GGO伴实变,7例有条索影伴或不伴GGO,8例有GGO伴小叶间隔增厚。
诊断标准与关键数值
- 无症状病例中胸部CT阳性率的汇总估计为63%(95%CI 44-78%)。
- 随访期间保持无症状者CT阳性率汇总为62%(95%CI 38-81%),出现症状者为90%(95%CI 49-99%)。
- 初诊无症状且CT阳性者后续出现症状的汇总率为26%(95%CI 14-43%)。
临床应用与阅片要点
- 阅片时对无症状但CT有GGO等异常者,应结合流行病学考虑COVID-19可能。
- 对影像学有异常的无症状病例,原文提出需密切临床监测以观察是否出现症状。
局限性
- 随访时间范围为7至30天。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To determine the overall rate of chest imaging findings in asymptomatic cases, describe the most common patterns found, and determine the rate of later symptom development in these initially asymptomatic cases.
MATERIALS AND METHODS: The PubMed and EMBASE databases were searched until 1 May 2020, for studies examining the proportion of positive chest imaging findings in asymptomatic cases diagnosed with COVID-19 and a random-effects meta-analysis of proportions was performed. Heterogeneity was assessed using the I2 statistic.
RESULTS: Among 858 non-duplicate studies, seven studies with a total of 231 asymptomatic cases met the inclusion criteria. In the primary analysis, the pooled estimate of the overall rate of positive chest computed tomography (CT) findings among asymptomatic cases was 63% (95% confidence interval [CI]: 44-78%). Among 155/231 cases that were followed up for later symptom development, 90/155 remained asymptomatic and 65/155 developed symptoms during the study period (that ranged between seven and 30 days of follow-up). The pooled estimate of the rate of positive chest CT findings was 62% (95% CI: 38-81%) in cases that remained asymptomatic, while it was 90% (95% CI: 49-99%) in cases that developed symptoms. Among CT findings, the pooled estimate of the overall rate of ground-glass opacities (GGO) at CT alone was 71% (95% CI: 50-86%). Among other CT findings reported, 22/231 patients had GGO with consolidation, 7/231 patients had stripe shadows with or without GGO, and 8/231 patients had GGO with interlobular septal thickening. Among initially asymptomatic cases with positive CT findings, the pooled estimate of the overall rate of later symptom development was 26% (95% CI: 14-43%).
CONCLUSION: In COVID-19, asymptomatic cases can have positive chest CT findings, and COVID-19 should be considered among cases with CT abnormalities even when there are no other symptoms. There is a need for close clinical monitoring of asymptomatic cases with radiographic findings as a significant percentage will develop symptoms.
引用
- Tsikala Vafea M, Atalla E, Kalligeros M, et al. Chest CT findings in asymptomatic cases with COVID-19: a systematic review and meta-analysis. Clin Radiol. 2020. PMID: 32861461. doi:10.1016/j.crad.2020.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。